US Stock MarketDetailed Quotes
ZVSA ZyVersa Therapeutics
- 0.6355
- -0.0745-10.49%
Close Apr 15 16:00 ET
4.83MMarket Cap-24P/E (TTM)
0.7300High0.6300Low461.43KVolume0.7199Open0.7100Pre Close316.14KTurnover6.16%Turnover RatioLossP/E (Static)7.59MShares90.650052wk High0.44P/B4.76MFloat Cap0.500052wk Low--Dividend TTM7.50MShs Float875.0000Historical High--Div YieldTTM14.09%Amplitude0.5000Historical Low0.6850Avg Price1Lot Size
About ZyVersa Therapeutics Company
ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It develops drugs for the treatment of renal and inflammatory diseases. The company was founded by Stephen C. Glover in 2014 and is headquartered in Weston, FL.
Company Profile
SymbolZVSA
Company NameZyVersa Therapeutics
Listing Date02/10/2022
Founded2014
CEOMr. Stephen C. Glover
MarketNASDAQ
Employees7
Securities TypeOrdinary Shares
Fiscal Year Ends01-01
Address2200 North Commerce Parkway,Suite 208
CityWeston
ProvinceFlorida
CountryUnited States of America
Zip Code33326
Phone1-754-231-1688
Websitehttp://www.zyversa.com
Company Executives
- Name
- Position
- Salary
- Stephen C. Glover
- Chairman of the Board, Chief Executive Officer and President
- 1.48M
- Peter Wolfe
- Chief Financial Officer, Secretary and Principal Accounting Officer
- 557.62K
- Karen A. Cashmere
- Chief Commercial Officer
- 582.62K
- Pablo A. Guzman, M.D.
- Chief Medical Officer and Senior Vice President, Medical Affairs
- --
- Gregory G. Freitag, C.P.A.,J.D.
- Director
- --
- Robert G. Finizio
- Director
- 165.47K
- James Sapirstein
- Director
- --
- Dr. Min-Chul Park, Pd.D
- Director
- 158.47K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg